The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.895
High: 0.895
Low: 0.895
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of 8th Mandatory Redemption

30 Dec 2020 07:00

RNS Number : 0641K
JPEL Private Equity Limited
30 December 2020
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

 

COMPLETION OF EIGHTH MANDATORY REDEMPTION

 

* * *

 

 

 

GUERNSEY, 30 DECEMBER 2020

 

 

The Board of Directors of JPEL Private Equity Limited ("JPEL" or the "Company") is pleased to announce that the partial mandatory redemption of the Company's US$ Equity Share class announced on 17 December 2020 has been completed with the redemption of 46,583,760 US$ Equity Shares ("Mandatory Redemption").

 

On 30 December 2020, JPEL redeemed 46,583,760 US$ Equity Shares, on a pro rata basis, at the prevailing NAV per US$ Equity Share of $1.61 as at 31 October 2020. Such shares were cancelled automatically following their redemption.

 

Fractions of shares produced by the applicable redemption ratios have not been redeemed and so the number of shares redeemed in respect of each shareholder has been rounded down to the nearest whole number of shares.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 8 January 2021. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or around 8 January 2021.

 

The US$ Equity Shares were disabled in CREST on the record date (29 December 2020) and the existing ISIN number GG00BMDQPC56 (the "Old ISIN") has expired. The new ISIN number GG00BNDVXN48 (the "New ISIN") in respect of the remaining 82,517,769 US$ Equity Shares which have not been redeemed will be enabled and will be available for transactions on 30 December 2020.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $414.2 million to US$ Equity Shareholders, or approximately 86.5% and 108.9% of the Company's 31 October 2016 NAV and market capitalization. Please note that the prevailing NAV at the time of the Company's first mandatory redemption was 31 October 2016.

 

 

DIRECTORS' INTERESTS

 

As a result of the Mandatory Redemption described above, Sean Hurst, Christopher Spencer and Tony Dalwood are expected, immediately following the redemption date, to hold approximately 6,086, 7,343 and 31,191 US$ Equity Shares, respectively.

 

 

* * *

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASMZMZZMLVGGZZ
Date   Source Headline
23rd Oct 20145:12 pmRNSTransaction in Own Shares
15th Oct 20147:00 amRNSNet Asset Value(s)
3rd Oct 20147:00 amRNSAnnual Financial Report
30th Sep 20145:16 pmRNSHolding(s) in Company
29th Sep 20145:35 pmRNSHolding(s) in Company
19th Sep 20145:03 pmRNSTransaction in Own Shares
18th Sep 20146:18 pmRNSHolding(s) in Company
18th Sep 20147:00 amRNSNet Asset Value(s)
15th Sep 20143:43 pmRNSHolding(s) in Company
12th Sep 20144:59 pmRNSHolding(s) in Company
11th Sep 20144:23 pmRNSHolding(s) in Company
10th Sep 20145:39 pmRNSHolding(s) in Company
22nd Aug 20144:00 pmRNSAdmission of Shares
7th Aug 20147:00 amRNSNet Asset Value(s) & Quarter End Review June 2014
4th Aug 20147:00 amRNSDisposal
16th Jul 201410:12 amRNSDirector Declaration
1st Jul 20144:51 pmRNSHolding(s) in Company
1st Jul 20147:00 amRNSNet Asset Value(s)
20th Jun 20147:00 amRNSExtension of Existing Credit Facility
19th Jun 20144:03 pmRNSHolding(s) in Company
9th Jun 20147:00 amRNSNet Asset Value(s)
22nd May 20147:00 amRNSPartial Exit
13th May 20146:10 pmRNSNet Asset Value(s)
2nd May 201410:02 amRNSResult of AGM
30th Apr 20145:03 pmRNSSignificant Investment Progress Announcement
4th Apr 201411:30 amRNSAGM Circular
1st Apr 20145:56 pmRNSNet Asset Value(s) & Monthly Report February 2014
14th Mar 20143:33 pmRNSNet Asset Value(s) and Monthly Report January 2014
26th Feb 20144:11 pmRNSHalf Yearly Report
11th Feb 20145:40 pmRNSMonthly Report - December 2013
11th Feb 20145:31 pmRNSNet Asset Value(s)
6th Feb 20145:09 pmRNSAppointment of Joint Corporate Broker
17th Jan 20145:47 pmRNSHolding(s) in Company
17th Jan 20144:39 pmRNSHolding(s) in Company
16th Jan 20146:06 pmRNSHolding(s) in Company
16th Jan 20146:05 pmRNSHolding(s) in Company
16th Jan 20145:56 pmRNSHolding(s) in Company
15th Jan 20147:00 amRNSStrategic Update
30th Dec 20135:11 pmRNSMonthly Report - November 2013
30th Dec 20135:08 pmRNSNet Asset Value(s)
5th Dec 201312:10 pmRNSMonthly Report - October 2013
5th Dec 201311:58 amRNSNet Asset Value(s)
26th Nov 20133:02 pmRNSHolding(s) in Company
25th Nov 20135:03 pmRNSHolding(s) in Company
20th Nov 20135:17 pmRNSHolding(s) in Company
20th Nov 20135:14 pmRNSHolding(s) in Company
13th Nov 20134:49 pmRNSMonthly Report - September 2013
13th Nov 20134:47 pmRNSNet Asset Value(s)
12th Nov 20135:39 pmRNSHolding(s) in Company
17th Oct 20134:46 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.